Curcumin: The potential for efficacy in gastrointestinal diseases

Best Practice and Research: Clinical Gastroenterology

Volumn 25, Issue 4-5, 2011, Pages 519-534

  Irving, Glen R B ^a   Karmokar, Ankur ^a   Berry, David P ^a   Brown, Karen ^a   Steward, William P ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Adenoma; Colorectal cancer; Curcumin; Inflammatory bowel disease; Pharmacology; Polyps

Indexed keywords

CURCUMIN; GEMCITABINE; K RAS PROTEIN; MESALAZINE; QUERCETIN;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOATING; CELL CYCLE ARREST; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; CROHN DISEASE; DIARRHEA; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FLATULENCE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TOXICITY; GINGER; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NAUSEA; NONHUMAN; PANCREAS CANCER; PANCREATITIS; SIDE EFFECT; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CURCUMIN; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; HUMANS; TREATMENT OUTCOME;

EID: 82455168251     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2011.09.005     Document Type: Article

References (96)

1. R.A. Sharma, H.R. McLelland, K.A. Hill, C.R. Ireson, S.A. Euden, and M.M. Manson Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer Clin Cancer Res 7 7 2001 Jul 1894 1900 (Pubitemid 32994823)
2. B.B. Aggarwal, C. Sundaram, N. Malani, and H. Ichikawa Curcumin: the Indian solid gold Adv Exp Med Biol 595 2007 1 75
3. E.V. Loftus Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences Gastroenterology 126 6 2004 May 1504 1517 (Pubitemid 38649869)
4. World Health Organisation. Cancer incidence and mortality worldwide in 2008. Available from: http://globocan.iarc.fr/.
5. F. Kiuchi, Y. Goto, N. Sugimoto, N. Akao, K. Kondo, and Y. Tsuda Nematocidal activity of turmeric: synergistic action of curcuminoids Chem Pharm Bull (Tokyo) 41 9 1993 Sep 1640 1643 (Pubitemid 23326798)
6. I. Rahman, S.K. Biswas, and P.A. Kirkham Regulation of inflammation and redox signaling by dietary polyphenols Biochem Pharmacol 72 11 2006 Nov 30 1439 1452 (Pubitemid 44666744)
7. 13C-labeled precursors Biosci Biotechnol Biochem 72 7 2008 Jul 1789 1798
8. K. Balasubramanian Molecular orbital basis for yellow curry spice curcumin's prevention of Alzheimer's disease J Agric Food Chem 54 10 2006 May 17 3512 3520 (Pubitemid 43844175)
9. K.I. Priyadarsini, D.K. Maity, G.H. Naik, M.S. Kumar, M.K. Unnikrishnan, and J.G. Satav Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin Free Radic Biol Med 35 5 2003 Sep 1 475 484 (Pubitemid 37289157)
10. W.M. Weber, L.A. Hunsaker, S.F. Abcouwer, L.M. Deck, and D.L. Vander Jagt Anti-oxidant activities of curcumin and related enones Bioorg Med Chem 13 11 2005 Jun 1 3811 3820 (Pubitemid 40615931)
11. L.R. Barclay, M.R. Vinqvist, K. Mukai, H. Goto, Y. Hashimoto, and A. Tokunaga On the antioxidant mechanism of curcumin: classical methods are needed to determine antioxidant mechanism and activity Org Lett 2 18 2000 Sep 7 2841 2843
12. J.K. Lin, M.H. Pan, and S.Y. Lin-Shiau Recent studies on the biofunctions and biotransformations of curcumin Biofactors 13 1-4 2000 153 158
13. Y.J. Wang, M.H. Pan, A.L. Cheng, L.I. Lin, Y.S. Ho, and C.Y. Hsieh Stability of curcumin in buffer solutions and characterization of its degradation products J Pharm Biomed Anal 15 12 1997 Aug 1867 1876
14. L. Li, F.S. Braiteh, and R. Kurzrock Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis Cancer 104 6 2005 Sep 15 1322 1331 (Pubitemid 41282806)
15. L. Li, B.B. Aggarwal, S. Shishodia, J. Abbruzzese, and R. Kurzrock Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis Cancer 101 10 2004 Nov 15 2351 2362 (Pubitemid 39458693)
16. F.R. Greten, L. Eckmann, T.F. Greten, J.M. Park, Z.W. Li, and L.J. Egan IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 118 3 2004 Aug 6 285 296 (Pubitemid 39061110)
17. S. Aggarwal, H. Ichikawa, Y. Takada, S.K. Sandur, S. Shishodia, and B.B. Aggarwal Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation Mol Pharmacol 69 1 2006 Jan 195 206 (Pubitemid 43048906)
18. A.B. Kunnumakkara, P. Diagaradjane, P. Anand, H.B. Kuzhuvelil, A. Deorukhkar, and J. Gelovani Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model Int J Cancer 125 9 2009 Nov 1 2187 2197
19. K.W. Lee, J.H. Kim, H.J. Lee, and Y.J. Surh Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells Antioxid Redox Signal 7 11-12 2005 Nov-Dec 1612 1620 (Pubitemid 41767996)
20. S.M. Plummer, K.A. Hill, M.F. Festing, W.P. Steward, A.J. Gescher, and R.A. Sharma Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents Cancer Epidemiol Biomarkers Prev 10 12 2001 Dec 1295 1299 (Pubitemid 34027762)
21. C.V. Rao, A. Rivenson, B. Simi, and B.S. Reddy Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound Cancer Res 55 2 1995 Jan 15 259 266
22. B.B. Aggarwal Prostate cancer and curcumin: add spice to your life Cancer Biol Ther 7 9 2008 Sep 1436 1440
23. ®, a curcumin- phosphatidylcholine complex, during extended administration in osteoarthritis patients Altern Med Rev 15 4 2010 Dec 337 344
24. ®, a curcumin-phosphatidylcholine complex, for the complementary management of osteoarthritis Panminerva Med 52 2 Suppl. 1 2010 Jun 55 62
25. S. Durgaprasad, C.G. Pai, Vasanthkumar, J.F. Alvres, and S. Namitha A pilot study of the antioxidant effect of curcumin in tropical pancreatitis Indian J Med Res 122 4 2005 Oct 315 318 (Pubitemid 43091515)
26. P.R. Holt, S. Katz, and R. Kirshoff Curcumin therapy in inflammatory bowel disease: a pilot study Dig Dis Sci 50 11 2005 Nov 2191 2193 (Pubitemid 41504112)
27. S. Sharma, S.K. Kulkarni, J.N. Agrewala, and K. Chopra Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain Eur J Pharmacol 536 3 2006 May 1 256 261
28. C. Billerey-Larmonier, J.K. Uno, N. Larmonier, A.J. Midura, B. Timmermann, and F.K. Ghishan Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent Inflamm Bowel Dis 14 6 2008 Jun 780 793 (Pubitemid 351898063)
29. H. Hanai, T. Iida, K. Takeuchi, F. Watanabe, Y. Maruyama, and A. Andoh Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial Clin Gastroenterol Hepatol 4 12 2006 Dec 1502 1506 (Pubitemid 44880023)
30. C.B. Larmonier, M.T. Midura-Kiela, R. Ramalingam, D. Laubitz, N. Janikashvili, and N. Larmonier Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease Inflamm Bowel Dis 17 2 2011 Feb 503 515
31. M. Churchill, A. Chadburn, R.T. Bilinski, and M.M. Bertagnolli Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile J Surg Res 89 2 2000 Apr 169 175 (Pubitemid 30196521)
32. S.S. Han, S.T. Chung, D.A. Robertson, D. Ranjan, and S. Bondada Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53 Clin Immunol 93 2 1999 Nov 152 161 (Pubitemid 29523391)
33. S. Bhaumik, M.D. Jyothi, and A. Khar Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells FEBS Lett 483 1 2000 Oct 13 78 82
34. B. Joe, and B.R. Lokesh Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages Biochim Biophys Acta 1224 2 1994 Nov 10 255 263
35. A.S. Jaiswal, B.P. Marlow, N. Gupta, and S. Narayan Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells Oncogene 21 55 2002 Dec 5 8414 8427 (Pubitemid 36061200)
36. R. Hanif, L. Qiao, S.J. Shiff, and B. Rigas Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway J Lab Clin Med 130 6 1997 Dec 576 584 (Pubitemid 28029226)
37. V. Basile, E. Ferrari, S. Lazzari, S. Belluti, F. Pignedoli, and C. Imbriano Curcumin derivatives: molecular basis of their anti-cancer activity Biochem Pharmacol 78 10 2009 Nov 15 1305 1315
38. B. Du, L. Jiang, Q. Xia, and L. Zhong Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29 Chemotherapy 52 1 2006 23 28 (Pubitemid 43004433)
39. S.P. Verma, B.R. Goldin, and P.S. Lin The inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoids Environ Health Perspect 106 12 1998 Dec 807 812 (Pubitemid 29073825)
40. L.M. Howells, A. Mitra, and M.M. Manson Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines Int J Cancer 121 1 2007 Jul 1 175 183 (Pubitemid 46753866)
41. M. Notarbartolo, P. Poma, D. Perri, L. Dusonchet, M. Cervello, and N. D'Alessandro Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression Cancer Lett 224 1 2005 Jun 16 53 65 (Pubitemid 40720367)
42. V. Milacic, S. Banerjee, K.R. Landis-Piwowar, F.H. Sarkar, A.P. Majumdar, and Q.P. Dou Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo Cancer Res 68 18 2008 Sep 15 7283 7292
43. R.J. Anto, A. Mukhopadhyay, K. Denning, and B.B. Aggarwal Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl Carcinogenesis 23 1 2002 Jan 143 150 (Pubitemid 34213563)
44. T. Choudhuri, S. Pal, M.L. Agwarwal, T. Das, and G. Sa Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction FEBS Lett 512 1-3 2002 Feb 13 334 340 (Pubitemid 34164505)
45. N.M. Weir, K. Selvendiran, V.K. Kutala, L. Tong, S. Vishwanath, and M. Rajaram Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating Akt and p38 MAPK Cancer Biol Ther 6 2 2007 Feb 178 184 (Pubitemid 46641620)
46. M.S. Squires, E.A. Hudson, L. Howells, S. Sale, C.E. Houghton, and J.L. Jones Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells Biochem Pharmacol 65 3 2003 Feb 1 361 376 (Pubitemid 36084553)
47. T.L. Chiu, and C.C. Su Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells Int J Mol Med 23 4 2009 Apr 469 475
48. J.L. Arbiser, N. Klauber, R. Rohan, R. van Leeuwen, M.T. Huang, and C. Fisher Curcumin is an in vivo inhibitor of angiogenesis Mol Med 4 6 1998 Jun 376 383 (Pubitemid 28387896)
49. B.B. Aggarwal, A. Kumar, and A.C. Bharti Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res 23 1A 2003 Jan-Feb 363 398 (Pubitemid 36361976)
50. B.B. Aggarwal, S. Shishodia, Y. Takada, S. Banerjee, R.A. Newman, and C.E. Bueso-Ramos Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice Clin Cancer Res 11 20 2005 Oct 15 7490 7498 (Pubitemid 41507710)
51. Z. Wang, Y. Li, A. Ahmad, A.S. Azmi, D. Kong, and S. Banerjee Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance Drug Resist Updat 13 4-5 2010 Aug-Oct 109 118
52. N. Shafee, C.R. Smith, S. Wei, Y. Kim, G.B. Mills, and G.N. Hortobagyi Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors Cancer Res 68 9 2008 May 1 3243 3250
53. F.C. Bidard, C. Tournigand, T. Andre, M. Mabro, A. Figer, and A. Cervantes Efficacy of FOLFIRI-3 (irinotecan D1, D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study Ann Oncol 20 6 2009 Jun 1042 1047
54. P.C. Hermann, S.L. Huber, T. Herrler, A. Aicher, J.W. Ellwart, and M. Guba Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 3 2007 Sep 13 313 323 (Pubitemid 47355323)
55. F.H. Sarkar, Y. Li, Z. Wang, and D. Kong The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer Cancer Metastasis Rev 29 3 2010 Sep 383 394
56. M.J. Ryu, M. Cho, J.Y. Song, Y.S. Yun, I.W. Choi, and D.E. Kim Natural derivatives of curcumin attenuate the Wnt/beta-catenin pathway through down-regulation of the transcriptional coactivator p300 Biochem Biophys Res Commun 377 4 2008 Dec 26 1304 1308
57. Z. Wang, S. Desmoulin, S. Banerjee, D. Kong, Y. Li, and R.L. Deraniyagala Synergistic effects of multiple natural products in pancreatic cancer cells Life Sci 83 7-8 2008 Aug 15 293 300
58. Kakarala M, Brenner DE, Korkaya H, Cheng C, Tazi K, Ginestier C et-al. Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat. Aug;122(3):777-785.
59. C.P. Prasad, G. Rath, S. Mathur, D. Bhatnagar, and R. Ralhan Potent growth suppressive activity of curcumin in human breast cancer cells: modulation of Wnt/beta-catenin signaling Chem Biol Interact 181 2 2009 Oct 7 263 271
60. Y. Yu, S.S. Kanwar, B.B. Patel, J. Nautiyal, F.H. Sarkar, and A.P. Majumdar Elimination of colon cancer stem-like cells by the combination of curcumin and FOLFOX Transl Oncol 2 4 2009 Dec 321 328
61. 3H]curcumin Toxicology 22 4 1981 337 344 (Pubitemid 12185120)
62. B. Wahlstrom, and G. Blennow A study on the fate of curcumin in the rat Acta Pharmacol Toxicol (Copenh) 43 2 1978 Aug 86 92 (Pubitemid 9016316)
63. G.M. Holder, J.L. Plummer, and A.J. Ryan The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat Xenobiotica 8 12 1978 Dec 761 768 (Pubitemid 9119050)
64. V. Ravindranath, and N. Chandrasekhara Absorption and tissue distribution of curcumin in rats Toxicology 16 3 1980 259 265 (Pubitemid 10056763)
65. G. Garcea, D.P. Berry, D.J. Jones, R. Singh, A.R. Dennison, and P.B. Farmer Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences Cancer Epidemiol Biomarkers Prev 14 1 2005 Jan 120 125 (Pubitemid 40165291)
66. R.A. Sharma, C.R. Ireson, R.D. Verschoyle, K.A. Hill, M.L. Williams, and C. Leuratti Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: relationship with drug levels Clin Cancer Res 7 5 2001 May 1452 1458 (Pubitemid 32708702)
67. G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P.S. Srinivas Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers Planta Med 64 4 1998 May 353 356 (Pubitemid 28234275)
68. S. Perkins, R.D. Verschoyle, K. Hill, I. Parveen, M.D. Threadgill, and R.A. Sharma Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis Cancer Epidemiol Biomarkers Prev 11 6 2002 Jun 535 540 (Pubitemid 34615160)
69. B. Shpitz, N. Giladi, E. Sagiv, S. Lev-Ari, E. Liberman, and D. Kazanov Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model Digestion 74 3-4 2006 140 144 (Pubitemid 46622782)
70. N. Dhillon, B.B. Aggarwal, R.A. Newman, R.A. Wolff, A.B. Kunnumakkara, and J.L. Abbruzzese Phase II trial of curcumin in patients with advanced pancreatic cancer Clin Cancer Res 14 14 2008 Jul 15 4491 4499
71. G. Garcea, D.J. Jones, R. Singh, A.R. Dennison, P.B. Farmer, and R.A. Sharma Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration Br J Cancer 90 5 2004 Mar 8 1011 1015 (Pubitemid 38499692)
72. M.M. LoTempio, M.S. Veena, H.L. Steele, B. Ramamurthy, T.S. Ramalingam, and A.N. Cohen Curcumin suppresses growth of head and neck squamous cell carcinoma Clin Cancer Res 11 19 Pt 1 2005 Oct 1 6994 7002 (Pubitemid 41428759)
73. R.A. Sharma, S.A. Euden, S.L. Platton, D.N. Cooke, A. Shafayat, and H.R. Hewitt Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance Clin Cancer Res 10 20 2004 Oct 15 6847 6854 (Pubitemid 39383033)
74. C.R. Ireson, D.J. Jones, S. Orr, M.W. Coughtrie, D.J. Boocock, and M.L. Williams Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine Cancer Epidemiol Biomarkers Prev 11 1 2002 Jan 105 111 (Pubitemid 34118319)
75. R.E. Carroll, R.V. Benya, D.K. Turgeon, S. Vareed, M. Neuman, and L. Rodriguez Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia Cancer Prev Res (Phila) 4 3 2011 Mar 354 364
76. V. Ravindranath, and N. Chandrasekhara In vitro studies on the intestinal absorption of curcumin in rats Toxicology 20 2-3 1981 251 257 (Pubitemid 11117911)
77. A.L. Cheng, C.H. Hsu, J.K. Lin, M.M. Hsu, Y.F. Ho, and T.S. Shen Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Res 21 4B 2001 Jul-Aug 2895 2900
78. D. Shoskes, C. Lapierre, M. Cruz-Correa, N. Muruve, R. Rosario, and B. Fromkin Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial Transplantation 80 11 2005 Dec 15 1556 1559 (Pubitemid 43005865)
79. R. Epelbaum, M. Schaffer, B. Vizel, V. Badmaev, and G. Bar-Sela Curcumin and gemcitabine in patients with advanced pancreatic cancer Nutr Cancer 62 8 2010 Nov 1137 1141
80. R.A. Sharma, W.P. Steward, and A.J. Gescher Pharmacokinetics and pharmacodynamics of curcumin Adv Exp Med Biol 595 2007 453 470
81. C. Braumann, N. Guenther, L.M. Loeffler, and W. Dubiel Liver metastases after colonic carcinoma - palliative chemotherapy plus curcumin Int J Colorectal Dis 24 7 2009 Jul 859 860
82. W. Hartojo, A.L. Silvers, D.G. Thomas, C.W. Seder, L. Lin, and H. Rao Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma Transl Oncol 3 2 2010 Apr 99 108
83. (Min/+) mice towards the chemopreventive efficacy of dietary aspirin and curcumin Br J Cancer 88 9 2003 May 6 1480 1483 (Pubitemid 36606434)
84. R.G. Tunstall, R.A. Sharma, S. Perkins, S. Sale, R. Singh, and P.B. Farmer Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: modification by dietary curcumin and implications for clinical trials Eur J Cancer 42 3 2006 Feb 415 421 (Pubitemid 43132899)
85. M. Cruz-Correa, D.A. Shoskes, P. Sanchez, R. Zhao, L.M. Hylind, and S.D. Wexner Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis Clin Gastroenterol Hepatol 4 8 2006 Aug 1035 1038 (Pubitemid 44118839)
86. F.A. Sinicrope, E. Half, J.S. Morris, P.M. Lynch, J.D. Morrow, and B. Levin Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients Cancer Epidemiol Biomarkers Prev 13 6 2004 Jun 920 927 (Pubitemid 38756701)
87. C.B. Larmonier, J.K. Uno, K.M. Lee, T. Karrasch, D. Laubitz, and R. Thurston Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection Am J Physiol Gastrointest Liver Physiol 295 5 2008 Nov G1079 G1091
88. B. Salh, K. Assi, V. Templeman, K. Parhar, D. Owen, and A. Gomez-Munoz Curcumin attenuates DNB-induced murine colitis Am J Physiol Gastrointest Liver Physiol 285 1 2003 Jul G235 G243
89. I. Villegas, S. Sanchez-Fidalgo, and C.A. de la Lastra Chemopreventive effect of dietary curcumin on inflammation-induced colorectal carcinogenesis in mice Mol Nutr Food Res 55 2 2011 Feb 259 267
90. L.M. Howells, S. Sale, S.N. Sriramareddy, G.R. Irving, D.J. Jones, and C.J. Ottley Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo Int J Cancer 129 2 2010 476 486
91. M. Khajavi, K. Shiga, W. Wiszniewski, F. He, C.A. Shaw, and J. Yan Oral curcumin mitigates the clinical and neuropathologic phenotype of the Trembler-J mouse: a potential therapy for inherited neuropathy Am J Hum Genet 81 3 2007 Sep 438 453 (Pubitemid 47330204)
92. Z.Y. He, C.B. Shi, H. Wen, F.L. Li, B.L. Wang, and J. Wang Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin Cancer Invest 29 3 2011 Mar 208 213
93. M. Kanai, K. Yoshimura, M. Asada, A. Imaizumi, C. Suzuki, and S. Matsumoto A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer Cancer Chemother Pharmacol 68 1 2011 157 164
94. J. Shaikh, D.D. Ankola, V. Beniwal, D. Singh, and M.N. Kumar Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer Eur J Pharm Sci 37 3-4 2009 Jun 28 223 230
95. T.H. Marczylo, R.D. Verschoyle, D.N. Cooke, P. Morazzoni, W.P. Steward, and A.J. Gescher Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine Cancer Chemother Pharmacol 60 2 2007 Jul 171 177 (Pubitemid 46742531)
96. J. Cuomo, G. Appendino, A.S. Dern, E. Schneider, T.P. McKinnon, and M.J. Brown Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation J Nat Prod 74 4 2011 Apr 25 664 669